Bega – Earnings Review

Bega recently provided a trading update, with FY22 underlying EBITDA expected to be in the range of
A$195-215mn.

Earnings have been impacted by supply chain-related disruptions, with some offset by the full-year contribution of the Lion Dairy & Drinks acquisition and related cost synergies. FY23 earnings should reaccelerate and recent shareholder support from Andrew Forrest suggests the current price range is a good opportunity to build a position.

COH – Algo Buy Signal

Cochlear is now under Algo Engine buy conditions and has been added to our ASX 100 model portfolio.

COH has rallied from $175 to a high of $257. The subsequent pullback has seen buying interest rebuild at the higher low of $207. This is the second cluster of Algo Engine buy signals and we’ve taken the opportunity to add to our original allocation.